chr16:69745145:G>A Detail (hg19) (NQO1)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr16:69,745,145-69,745,145 |
hg38 | chr16:69,711,242-69,711,242 View the variant detail on this assembly version. |
HGVS
Type | Transcript | Protein |
---|---|---|
RefSeq | NM_001025434.1:c.445C>T | NP_001020605.1:p.Pro149Ser |
NM_001025433.1:c.457C>T | NP_001020604.1:p.Pro153Ser | |
NM_001286137.1:c.457C>T | NP_001273066.1:p.Pro153Ser |
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
JP | HGVD:0.387 |
ToMMo:0.370 | |
NCBN:[No Data.] | |
NCBN(Hondo):[No Data.] | |
NCBN(Ryukyu):[No Data.] | |
East asia | ExAC:0.450 |
Prediction
ClinVar
Clinical Significance |
![]() |
Review star | ![]() |
Show details |
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
Clinical significance | Last evaluated | Review status | Condition | Origin | Links |
---|---|---|---|---|---|
![]() |
2008-07-01 | no assertion criteria provided | Benzene toxicity, susceptibility to |
![]() |
Detail |
![]() |
2008-07-01 | no assertion criteria provided | Leukemia, post-chemotherapy, susceptibility to |
![]() |
Detail |
![]() |
2008-07-01 | no assertion criteria provided | Breast cancer, post-chemotherapy poor survival in |
![]() |
Detail |
![]() |
2016-03-10 | no assertion provided | lung carcinoma |
![]() |
Detail |
![]() |
2019-10-17 | criteria provided, single submitter | NQO1-related disorder |
![]() |
Detail |
CIViC
Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
---|---|---|---|---|---|---|---|---|---|
lung cancer | Amrubicin | D |
![]() |
![]() |
Sensitivity/Response | Common Germline | 2 | 21964527 | Detail |
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.003 | Adenoma of large intestine | Although with modest limitations and biases, this metaanalysis suggests that EPH... | BeFree | 22161138 | Detail |
<0.001 | Adenoma of large intestine | Although with modest limitations and biases, this metaanalysis suggests that EPH... | BeFree | 22161138 | Detail |
0.001 | Adenoma of large intestine | Although with modest limitations and biases, this metaanalysis suggests that EPH... | BeFree | 22161138 | Detail |
<0.001 | pancreatic carcinoma | According to the assumption that genetic variation in carcinogen metabolism furt... | BeFree | 20966810 | Detail |
0.122 | pancreatic carcinoma | According to the assumption that genetic variation in carcinogen metabolism furt... | BeFree | 20966810 | Detail |
0.004 | Malignant neoplasm of pancreas | According to the assumption that genetic variation in carcinogen metabolism furt... | BeFree | 20966810 | Detail |
<0.001 | Malignant neoplasm of pancreas | According to the assumption that genetic variation in carcinogen metabolism furt... | BeFree | 20966810 | Detail |
0.240 | Malignant neoplasm of breast | Combining the two 'candidate' SNPs (P187S and R72P) revealed an increased risk f... | BeFree | 15138483 | Detail |
0.080 | breast carcinoma | Combining the two 'candidate' SNPs (P187S and R72P) revealed an increased risk f... | BeFree | 15138483 | Detail |
0.001 | Malignant tumor of cervix | Polymorphisms in TP53 (rs1042522), p16 (rs11515 and rs3088440) and NQO1 (rs18005... | BeFree | 23534750 | Detail |
0.001 | cervix carcinoma | Polymorphisms in TP53 (rs1042522), p16 (rs11515 and rs3088440) and NQO1 (rs18005... | BeFree | 23534750 | Detail |
0.003 | coronary artery disease | XRCC1 (rs1799782 and rs25487), XRCC3 (rs861539), MTHFR (rs1801133 and rs4846049)... | BeFree | 24315498 | Detail |
<0.001 | coronary artery disease | XRCC1 (rs1799782 and rs25487), XRCC3 (rs861539), MTHFR (rs1801133 and rs4846049)... | BeFree | 24315498 | Detail |
0.007 | breast carcinoma | The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from ... | BeFree | 24884893 | Detail |
0.002 | colorectal carcinoma | NAD(P)H:quinone oxidoreductase 1 (NQO1) rs1800566 polymorphism is found to have ... | BeFree | 22215148 | Detail |
<0.001 | Diabetes | No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) ... | BeFree | 10447260 | Detail |
0.002 | Malignant neoplasm of urinary bladder | Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and ... | BeFree | 23873104 | Detail |
0.026 | Malignant neoplasm of urinary bladder | The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptib... | BeFree | 25602258 | Detail |
0.030 | Malignant neoplasm of breast | The results of the study suggest that NQO1 exon 6 proline187serine (C609T) and C... | BeFree | 21329464 | Detail |
0.034 | colorectal cancer | Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism a... | BeFree | 22306249 | Detail |
0.026 | Malignant neoplasm of urinary bladder | The NQO1 rs1800566 polymorphism and risk of bladder cancer: evidence from 6,169 ... | BeFree | 23464456 | Detail |
0.001 | Tardive Dyskinesia | Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and mangan... | BeFree | 18977034 | Detail |
0.009 | Esophageal Neoplasms | NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esoph... | BeFree | 24354914 | Detail |
0.001 | lingual-facial-buccal dyskinesia | (2004) originally reported a significant association between TD and the NADPH qu... | BeFree | 19778569 | Detail |
0.004 | colorectal carcinoma | Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a ... | BeFree | 22215148 | Detail |
0.007 | breast carcinoma | Evidence on the association between NQO1 Pro187Ser polymorphism and breast cance... | BeFree | 20526805 | Detail |
0.036 | Malignant neoplasm of breast | The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from ... | BeFree | 24884893 | Detail |
0.010 | Tardive Dyskinesia | Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and mangan... | BeFree | 18977034 | Detail |
<0.001 | diabetes mellitus | No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) ... | BeFree | 10447260 | Detail |
<0.001 | Tardive Dyskinesia | Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and mangan... | BeFree | 18977034 | Detail |
<0.001 | Tardive Dyskinesia | Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and mangan... | BeFree | 18977034 | Detail |
0.036 | Malignant neoplasm of breast | NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic ... | BeFree | 18511948 | Detail |
<0.001 | Diabetes Mellitus, Insulin-Dependent | No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) ... | BeFree | 10447260 | Detail |
<0.001 | Tardive Dyskinesia | (2004) originally reported a significant association between TD and the NADPH qu... | BeFree | 19778569 | Detail |
0.034 | colorectal cancer | Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a ... | BeFree | 22215148 | Detail |
0.034 | colorectal cancer | NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of l... | BeFree | 16702380 | Detail |
0.026 | Malignant neoplasm of urinary bladder | Results of this study strongly suggest that the variant allele of NQO1 (Pro187Se... | BeFree | 21253823 | Detail |
0.002 | colorectal cancer | NAD(P)H:quinone oxidoreductase 1 (NQO1) rs1800566 polymorphism is found to have ... | BeFree | 22215148 | Detail |
0.004 | Squamous cell carcinoma of esophagus | The NQO1 rs1800566 TT genotype was associated with a decreased risk of ESCC in a... | BeFree | 24354914 | Detail |
0.007 | breast carcinoma | The results of the study suggest that NQO1 exon 6 proline187serine (C609T) and C... | BeFree | 21329464 | Detail |
<0.001 | Malignant neoplasm of stomach | quinone oxidoreductase 1 (NQO1) gene C609T polymorphism (rs1800566) and gastric ... | BeFree | 24716985 | Detail |
0.011 | Malignant neoplasm of esophagus | Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-an... | BeFree | 24213850 | Detail |
0.034 | colorectal cancer | NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal ca... | BeFree | 20593958 | Detail |
0.002 | esophageal carcinoma | NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esoph... | BeFree | 24354914 | Detail |
0.001 | breast carcinoma | NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic ... | BeFree | 18511948 | Detail |
0.009 | schizophrenia | Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and mangan... | BeFree | 18977034 | Detail |
<0.001 | Diabetes | No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) ... | BeFree | 10447260 | Detail |
0.004 | colorectal carcinoma | Meta-analysis of the association between NQO1 Pro187Ser polymorphism and colorec... | BeFree | 24142528 | Detail |
0.002 | colorectal carcinoma | NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal ca... | BeFree | 20593958 | Detail |
0.008 | Carcinoma of lung | In stratified analyses, the NQO1 Pro187Ser variant genotypes were associated wit... | BeFree | 16702380 | Detail |
<0.001 | stomach carcinoma | quinone oxidoreductase 1 (NQO1) gene C609T polymorphism (rs1800566) and gastric ... | BeFree | 24716985 | Detail |
0.002 | esophageal carcinoma | Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-an... | BeFree | 24213850 | Detail |
0.295 | diabetes mellitus | No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) ... | BeFree | 10447260 | Detail |
0.036 | Malignant neoplasm of breast | The results of the study suggest that NQO1 exon 6 proline187serine (C609T) and C... | BeFree | 21329464 | Detail |
0.004 | Carcinoma of bladder | The NQO1 rs1800566 polymorphism and risk of bladder cancer: evidence from 6,169 ... | BeFree | 23464456 | Detail |
0.371 | Diabetes Mellitus, Insulin-Dependent | No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) ... | BeFree | 10447260 | Detail |
0.001 | Malignant neoplasm of breast | NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic ... | BeFree | 18511948 | Detail |
0.004 | Carcinoma of bladder | Results of this study strongly suggest that the variant allele of NQO1 (Pro187Se... | BeFree | 21253823 | Detail |
0.080 | Diabetes | No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) ... | BeFree | 10447260 | Detail |
<0.001 | leukemia | The NQO1 rs1800566 (C609T), PON1 rs854560 (L55M), and PON1 rs662 (Q192R) polymor... | BeFree | 22976839 | Detail |
0.120 | Leukemia, post-chemotherapy, susceptibility to | NA | CLINVAR | Detail | |
0.002 | colorectal cancer | NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal ca... | BeFree | 20593958 | Detail |
0.024 | leukemia | The NQO1 rs1800566 (C609T), PON1 rs854560 (L55M), and PON1 rs662 (Q192R) polymor... | BeFree | 22976839 | Detail |
0.036 | Malignant neoplasm of breast | Evidence on the association between NQO1 Pro187Ser polymorphism and breast cance... | BeFree | 20526805 | Detail |
0.004 | colorectal carcinoma | Results from our meta-analyses suggest that the variant NQO1 Pro187Ser genotype ... | BeFree | 16702380 | Detail |
0.002 | Adenocarcinoma of lung (disorder) | In stratified analyses, the NQO1 Pro187Ser variant genotypes were associated wit... | BeFree | 16702380 | Detail |
0.004 | Carcinoma of lung | The association between NAD(P)H:quinone oxidoreductase 1 (NQO1) gene C609T polym... | BeFree | 23110137 | Detail |
0.004 | colorectal carcinoma | NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal ca... | BeFree | 20593958 | Detail |
<0.001 | Cancer of Urinary Tract | The association between NQO1 Pro187Ser polymorphism and urinary system cancer su... | BeFree | 25608636 | Detail |
<0.001 | schizophrenia | Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and mangan... | BeFree | 18977034 | Detail |
0.007 | breast carcinoma | NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic ... | BeFree | 18511948 | Detail |
<0.001 | acute leukemia | NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) polymorphis... | BeFree | 22976839 | Detail |
0.001 | lingual-facial-buccal dyskinesia | Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and mangan... | BeFree | 18977034 | Detail |
0.060 | Malignant neoplasm of lung | In stratified analyses, the NQO1 Pro187Ser variant genotypes were associated wit... | BeFree | 16702380 | Detail |
0.034 | colorectal cancer | Meta-analysis of the association between NQO1 Pro187Ser polymorphism and colorec... | BeFree | 24142528 | Detail |
0.019 | squamous cell carcinoma | In stratified analyses, the NQO1 Pro187Ser variant genotypes were associated wit... | BeFree | 16702380 | Detail |
<0.001 | schizophrenia | Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and mangan... | BeFree | 18977034 | Detail |
0.003 | Diabetes Mellitus, Insulin-Dependent | No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) ... | BeFree | 10447260 | Detail |
0.004 | Malignant neoplasm of lung | The association between NAD(P)H:quinone oxidoreductase 1 (NQO1) gene C609T polym... | BeFree | 23110137 | Detail |
0.010 | lingual-facial-buccal dyskinesia | Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and mangan... | BeFree | 18977034 | Detail |
0.009 | Esophageal Neoplasms | Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-an... | BeFree | 24213850 | Detail |
<0.001 | Leukemia, Myelocytic, Acute | The NQO1 rs1800566 (C609T), PON1 rs854560 (L55M), and PON1 rs662 (Q192R) polymor... | BeFree | 22976839 | Detail |
<0.001 | lingual-facial-buccal dyskinesia | Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and mangan... | BeFree | 18977034 | Detail |
0.017 | schizophrenia | Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and mangan... | BeFree | 18977034 | Detail |
0.002 | Malignant neoplasm of urinary bladder | The NAD(P)H:quinone oxidoreductase 1 (NQO1) rs1800566 polymorphism, leading to p... | BeFree | 23464456 | Detail |
<0.001 | Malignant neoplasm of stomach stage IV | NQO1 rs1800566 is an independent predictive factor of PFS for MGC patients treat... | BeFree | 25545243 | Detail |
<0.001 | mitral valve stenosis | Our results indicate that NQO1 rs1800566 does not have an effect on MS disease r... | BeFree | 24755231 | Detail |
0.004 | colorectal carcinoma | Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism a... | BeFree | 22306249 | Detail |
0.006 | breast carcinoma | The results of the study suggest that NQO1 exon 6 proline187serine (C609T) and C... | BeFree | 21329464 | Detail |
0.002 | Carcinoma of bladder | The NAD(P)H:quinone oxidoreductase 1 (NQO1) rs1800566 polymorphism, leading to p... | BeFree | 23464456 | Detail |
0.002 | Carcinoma of bladder | Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and ... | BeFree | 23873104 | Detail |
0.001 | Adenoma of large intestine | Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism a... | BeFree | 22306249 | Detail |
0.002 | colorectal cancer | NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of l... | BeFree | 16702380 | Detail |
0.001 | Tardive Dyskinesia | (2004) originally reported a significant association between TD and the NADPH qu... | BeFree | 19778569 | Detail |
0.004 | Carcinoma of bladder | The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptib... | BeFree | 25602258 | Detail |
<0.001 | Squamous cell carcinoma of esophagus | quinone oxidoreductase 1 (NQO1) rs1800566 C>T and NQO2 rs2070999 G>A singl... | BeFree | 24354914 | Detail |
<0.001 | diabetes mellitus | No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) ... | BeFree | 10447260 | Detail |
<0.001 | lingual-facial-buccal dyskinesia | Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and mangan... | BeFree | 18977034 | Detail |
<0.001 | lingual-facial-buccal dyskinesia | (2004) originally reported a significant association between TD and the NADPH qu... | BeFree | 19778569 | Detail |
0.011 | Malignant neoplasm of esophagus | NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esoph... | BeFree | 24354914 | Detail |
0.024 | leukemia | RAS mutations in early age leukaemia modulated by NQO1 rs1800566 (C609T) are ass... | BeFree | 24571676 | Detail |
<0.001 | Bladder Neoplasm | Patients with urinary bladder neoplasms who had been followed up for a 5-year pe... | BeFree | 17469025 | Detail |
0.023 | Bladder Neoplasm | Patients with urinary bladder neoplasms who had been followed up for a 5-year pe... | BeFree | 17469025 | Detail |
0.133 | Bladder Neoplasm | Patients with urinary bladder neoplasms who had been followed up for a 5-year pe... | BeFree | 17469025 | Detail |
0.218 | Bladder Neoplasm | Patients with urinary bladder neoplasms who had been followed up for a 5-year pe... | BeFree | 17469025 | Detail |
0.154 | Bladder Neoplasm | Patients with urinary bladder neoplasms who had been followed up for a 5-year pe... | BeFree | 17469025 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
The presence of NQO1 C609T SNP (rs1800566) was associated with decreased protein expression and high... | CIViC Evidence | Detail |
NM_000903.3(NQO1):c.559C>T (p.Pro187Ser) AND Benzene toxicity, susceptibility to | ClinVar | Detail |
NM_000903.3(NQO1):c.559C>T (p.Pro187Ser) AND Leukemia, post-chemotherapy, susceptibility to | ClinVar | Detail |
NM_000903.3(NQO1):c.559C>T (p.Pro187Ser) AND Breast cancer, post-chemotherapy poor survival in | ClinVar | Detail |
NM_000903.3(NQO1):c.559C>T (p.Pro187Ser) AND Lung carcinoma | ClinVar | Detail |
NM_000903.3(NQO1):c.559C>T (p.Pro187Ser) AND NQO1-related disorder | ClinVar | Detail |
Although with modest limitations and biases, this metaanalysis suggests that EPHX1 Tyr113His and His... | DisGeNET | Detail |
Although with modest limitations and biases, this metaanalysis suggests that EPHX1 Tyr113His and His... | DisGeNET | Detail |
Although with modest limitations and biases, this metaanalysis suggests that EPHX1 Tyr113His and His... | DisGeNET | Detail |
According to the assumption that genetic variation in carcinogen metabolism further modifies the ris... | DisGeNET | Detail |
According to the assumption that genetic variation in carcinogen metabolism further modifies the ris... | DisGeNET | Detail |
According to the assumption that genetic variation in carcinogen metabolism further modifies the ris... | DisGeNET | Detail |
According to the assumption that genetic variation in carcinogen metabolism further modifies the ris... | DisGeNET | Detail |
Combining the two 'candidate' SNPs (P187S and R72P) revealed an increased risk for breast cancer of ... | DisGeNET | Detail |
Combining the two 'candidate' SNPs (P187S and R72P) revealed an increased risk for breast cancer of ... | DisGeNET | Detail |
Polymorphisms in TP53 (rs1042522), p16 (rs11515 and rs3088440) and NQO1 (rs1800566) genes in Thai ce... | DisGeNET | Detail |
Polymorphisms in TP53 (rs1042522), p16 (rs11515 and rs3088440) and NQO1 (rs1800566) genes in Thai ce... | DisGeNET | Detail |
XRCC1 (rs1799782 and rs25487), XRCC3 (rs861539), MTHFR (rs1801133 and rs4846049), and NQO1 (rs180056... | DisGeNET | Detail |
XRCC1 (rs1799782 and rs25487), XRCC3 (rs861539), MTHFR (rs1801133 and rs4846049), and NQO1 (rs180056... | DisGeNET | Detail |
The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-anal... | DisGeNET | Detail |
NAD(P)H:quinone oxidoreductase 1 (NQO1) rs1800566 polymorphism is found to have a lower enzymatic ac... | DisGeNET | Detail |
No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) and type 1 diabetes ... | DisGeNET | Detail |
Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder canc... | DisGeNET | Detail |
The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptibility: a meta-analys... | DisGeNET | Detail |
The results of the study suggest that NQO1 exon 6 proline187serine (C609T) and CYP1A2 exon 2 phenyla... | DisGeNET | Detail |
Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorecta... | DisGeNET | Detail |
The NQO1 rs1800566 polymorphism and risk of bladder cancer: evidence from 6,169 subjects. | DisGeNET | Detail |
Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismu... | DisGeNET | Detail |
NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Ch... | DisGeNET | Detail |
(2004) originally reported a significant association between TD and the NADPH quinine oxidoreductase... | DisGeNET | Detail |
Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis. | DisGeNET | Detail |
Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the curren... | DisGeNET | Detail |
The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-anal... | DisGeNET | Detail |
Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismu... | DisGeNET | Detail |
No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) and type 1 diabetes ... | DisGeNET | Detail |
Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismu... | DisGeNET | Detail |
Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismu... | DisGeNET | Detail |
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive facto... | DisGeNET | Detail |
No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) and type 1 diabetes ... | DisGeNET | Detail |
(2004) originally reported a significant association between TD and the NADPH quinine oxidoreductase... | DisGeNET | Detail |
Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis. | DisGeNET | Detail |
NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and co... | DisGeNET | Detail |
Results of this study strongly suggest that the variant allele of NQO1 (Pro187Ser) may affect indivi... | DisGeNET | Detail |
NAD(P)H:quinone oxidoreductase 1 (NQO1) rs1800566 polymorphism is found to have a lower enzymatic ac... | DisGeNET | Detail |
The NQO1 rs1800566 TT genotype was associated with a decreased risk of ESCC in a Chinese population. | DisGeNET | Detail |
The results of the study suggest that NQO1 exon 6 proline187serine (C609T) and CYP1A2 exon 2 phenyla... | DisGeNET | Detail |
quinone oxidoreductase 1 (NQO1) gene C609T polymorphism (rs1800566) and gastric cancer has been wide... | DisGeNET | Detail |
Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis. | DisGeNET | Detail |
NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition ... | DisGeNET | Detail |
NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Ch... | DisGeNET | Detail |
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive facto... | DisGeNET | Detail |
Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismu... | DisGeNET | Detail |
No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) and type 1 diabetes ... | DisGeNET | Detail |
Meta-analysis of the association between NQO1 Pro187Ser polymorphism and colorectal cancer in Asians... | DisGeNET | Detail |
NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition ... | DisGeNET | Detail |
In stratified analyses, the NQO1 Pro187Ser variant genotypes were associated with slightly increased... | DisGeNET | Detail |
quinone oxidoreductase 1 (NQO1) gene C609T polymorphism (rs1800566) and gastric cancer has been wide... | DisGeNET | Detail |
Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis. | DisGeNET | Detail |
No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) and type 1 diabetes ... | DisGeNET | Detail |
The results of the study suggest that NQO1 exon 6 proline187serine (C609T) and CYP1A2 exon 2 phenyla... | DisGeNET | Detail |
The NQO1 rs1800566 polymorphism and risk of bladder cancer: evidence from 6,169 subjects. | DisGeNET | Detail |
No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) and type 1 diabetes ... | DisGeNET | Detail |
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive facto... | DisGeNET | Detail |
Results of this study strongly suggest that the variant allele of NQO1 (Pro187Ser) may affect indivi... | DisGeNET | Detail |
No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) and type 1 diabetes ... | DisGeNET | Detail |
The NQO1 rs1800566 (C609T), PON1 rs854560 (L55M), and PON1 rs662 (Q192R) polymorphisms modified risk... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition ... | DisGeNET | Detail |
The NQO1 rs1800566 (C609T), PON1 rs854560 (L55M), and PON1 rs662 (Q192R) polymorphisms modified risk... | DisGeNET | Detail |
Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the curren... | DisGeNET | Detail |
Results from our meta-analyses suggest that the variant NQO1 Pro187Ser genotype may affect individua... | DisGeNET | Detail |
In stratified analyses, the NQO1 Pro187Ser variant genotypes were associated with slightly increased... | DisGeNET | Detail |
The association between NAD(P)H:quinone oxidoreductase 1 (NQO1) gene C609T polymorphism (rs1800566) ... | DisGeNET | Detail |
NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition ... | DisGeNET | Detail |
The association between NQO1 Pro187Ser polymorphism and urinary system cancer susceptibility: a meta... | DisGeNET | Detail |
Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismu... | DisGeNET | Detail |
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive facto... | DisGeNET | Detail |
NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) polymorphisms segregate the ris... | DisGeNET | Detail |
Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismu... | DisGeNET | Detail |
In stratified analyses, the NQO1 Pro187Ser variant genotypes were associated with slightly increased... | DisGeNET | Detail |
Meta-analysis of the association between NQO1 Pro187Ser polymorphism and colorectal cancer in Asians... | DisGeNET | Detail |
In stratified analyses, the NQO1 Pro187Ser variant genotypes were associated with slightly increased... | DisGeNET | Detail |
Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismu... | DisGeNET | Detail |
No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) and type 1 diabetes ... | DisGeNET | Detail |
The association between NAD(P)H:quinone oxidoreductase 1 (NQO1) gene C609T polymorphism (rs1800566) ... | DisGeNET | Detail |
Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismu... | DisGeNET | Detail |
Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis. | DisGeNET | Detail |
The NQO1 rs1800566 (C609T), PON1 rs854560 (L55M), and PON1 rs662 (Q192R) polymorphisms modified risk... | DisGeNET | Detail |
Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismu... | DisGeNET | Detail |
Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismu... | DisGeNET | Detail |
The NAD(P)H:quinone oxidoreductase 1 (NQO1) rs1800566 polymorphism, leading to proline- toserine ami... | DisGeNET | Detail |
NQO1 rs1800566 is an independent predictive factor of PFS for MGC patients treated with EOF chemothe... | DisGeNET | Detail |
Our results indicate that NQO1 rs1800566 does not have an effect on MS disease risk. | DisGeNET | Detail |
Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorecta... | DisGeNET | Detail |
The results of the study suggest that NQO1 exon 6 proline187serine (C609T) and CYP1A2 exon 2 phenyla... | DisGeNET | Detail |
The NAD(P)H:quinone oxidoreductase 1 (NQO1) rs1800566 polymorphism, leading to proline- toserine ami... | DisGeNET | Detail |
Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder canc... | DisGeNET | Detail |
Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorecta... | DisGeNET | Detail |
NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and co... | DisGeNET | Detail |
(2004) originally reported a significant association between TD and the NADPH quinine oxidoreductase... | DisGeNET | Detail |
The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptibility: a meta-analys... | DisGeNET | Detail |
quinone oxidoreductase 1 (NQO1) rs1800566 C>T and NQO2 rs2070999 G>A single-nucleotide polymor... | DisGeNET | Detail |
No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) and type 1 diabetes ... | DisGeNET | Detail |
Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismu... | DisGeNET | Detail |
(2004) originally reported a significant association between TD and the NADPH quinine oxidoreductase... | DisGeNET | Detail |
NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Ch... | DisGeNET | Detail |
RAS mutations in early age leukaemia modulated by NQO1 rs1800566 (C609T) are associated with second-... | DisGeNET | Detail |
Patients with urinary bladder neoplasms who had been followed up for a 5-year period were genotyped ... | DisGeNET | Detail |
Patients with urinary bladder neoplasms who had been followed up for a 5-year period were genotyped ... | DisGeNET | Detail |
Patients with urinary bladder neoplasms who had been followed up for a 5-year period were genotyped ... | DisGeNET | Detail |
Patients with urinary bladder neoplasms who had been followed up for a 5-year period were genotyped ... | DisGeNET | Detail |
Patients with urinary bladder neoplasms who had been followed up for a 5-year period were genotyped ... | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs1800566 dbSNP
- Genome
- hg19
- Position
- chr16:69,745,145-69,745,145
- Variant Type
- snv
- Reference Allele
- G
- Alternative Allele
- A
- Filtering Status (HGVD)
- PASS
- # of samples (HGVD)
- 1210
- Mean of sample read depth (HGVD)
- 192.04
- Standard deviation of sample read depth (HGVD)
- 82.32
- Number of reference allele (HGVD)
- 1484
- Number of alternative allele (HGVD)
- 936
- Allele Frequency (HGVD)
- 0.3867768595041322
- Gene Symbol (HGVD)
- NQO1
- ToMMo VCF FILTER column value (ToMMo 8.3KJPN Allele Frequency Panel(v20200831))
- PASS
- Total VCF ID column value (ToMMo 8.3KJPN Allele Frequency Panel(v20200831))
- rs1800566
- Allele frequency, for each ALT allele (ToMMo 8.3KJPN Allele Frequency Panel(v20200831))
- 0.3701
- Allele count in genotypes, for each ALT allele (ToMMo 8.3KJPN Allele Frequency Panel(v20200831))
- 6203
- Total number of alleles in called genotypes (ToMMo 8.3KJPN Allele Frequency Panel(v20200831))
- 16760
- East Asian Chromosome Counts (ExAC)
- 8646
- East Asian Allele Counts (ExAC)
- 3892
- East Asian Heterozygous Counts (ExAC)
- 2144
- East Asian Homozygous Counts (ExAC)
- 874
- East Asian Allele Frequency (ExAC)
- 0.4501503585473051
- Chromosome Counts in All Race (ExAC)
- 121132
- Allele Counts in All Race (ExAC)
- 29697
- Heterozygous Counts in All Race (ExAC)
- 21169
- Homozygous Counts in All Race (ExAC)
- 4264
- Allele Frequency in All Race (ExAC)
- 0.24516230228180827
- Variant (CIViC) (CIViC Variant)
- P187S
- Transcript 1 (CIViC Variant)
- ENST00000320623.5
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/402
Genome browser